CoChat

Cerebral Creatine Deficiency Syndromes: Clinical Aspects, Treatment and Pathophysiology

Stockler, Sylvia, Schutz, Peter W., Salomons, Gajja S. · 2007 · Subcellular Biochemistry

The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.

Abstract

Cerebral creatine deficiency syndromes (CCDSs) are a group of inborn errors of creatine metabolism comprising two autosomal recessive disorders that affect the biosynthesis of creatine--i.e. arginine:glycine amidinotransferase deficiency (AGAT; MIM 602360) and guanidinoacetate methyltransferase deficiency (GAMT; MIM 601240)--and an X-linked defect that affects the creatine transporter, SLC6A8 deficiency (SLC6A8; MIM 300036). The biochemical hallmarks of these disorders include cerebral creatine deficiency as detected in vivo by 1H magnetic resonance spectroscopy (MRS) of the brain, and specific disturbances in metabolites of creatine metabolism in body fluids. In urine and plasma, abnormal guanidinoacetic acid (GAA) levels are found in AGAT deficiency (reduced GAA) and in GAMT deficiency (increased GAA). In urine of males with SLC6A8 deficiency, an increased creatine/creatinine ratio is detected. The common clinical presentation in CCDS includes mental retardation, expressive speech and language delay, autistic like behaviour and epilepsy. Treatment of the creatine biosynthesis defects has yielded clinical improvement, while for creatine transporter deficiency, successful treatment strategies still need to be discovered. CCDSs may be responsible for a considerable fraction of children and adults affected with mental retardation of unknown etiology. Thus, screening for this group of disorders should be included in the differential diagnosis of this population. In this review, also the importance of CCDSs for the unravelling of the (patho)physiology of cerebral creatine metabolism is discussed.

Overview

Integrity signals

Registry

Crossref · 10.1007/978-1-4020-6486-9_8

Cites

67 of 67 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 67 references

Research works printed but not linked: 1

  1. De Vries, M., Morava, E., Rodenburg, R., Kluijtmans, L., Verhoeven, N.M., Salomons, G.S., Jakobs, C., and Smeitink, J., 2005, Mitochondrial dysfunction in creatine biosynthesis disorder. J. Inherit. Metab. Dis. 28: 227.

Cited by

See all 180

Metadata

Authors
Stockler, S., Schutz, P. W., & Salomons, G. S.
Affiliations
Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
Venue
Subcellular Biochemistry
Published
2007-10-15
Volume
46
Pages
149-166
OpenAlex
W185449676
Cited by
180
References
66
Citations by year
2026: 3 · 2025: 6 · 2024: 7 · 2023: 14 · 2022: 5 · 2021: 8 · 2020: 2 · 2019: 4 · 2018: 7 · 2016: 9 · 2015: 13 · 2014: 18 · 2013: 12 · 2012: 13
FWCI
41.92
Type
book chapter
Language
en
Open access
closed
Locations
  • Springer eBooks (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
Keywords
cerebral creatine deficiency syndrome, guanidinoacetate methyltransferase deficiency, creatine transporter deficiency, guanidinoacetic acid, 1H magnetic resonance spectroscopy, intellectual disability, epilepsy, autism-like behavior, creatine synthesis, differential diagnosis, screening
MeSH terms
Adult, Amidinotransferases, Animals, Cerebellar Diseases, Child, Child, Preschool, Creatine, Creatinine, Diagnosis, Differential, Female, Glycine, Humans, Male, Nerve Tissue Proteins, Syndrome, Brain Diseases, Metabolic, Inborn, Genetic Diseases, X-Linked, Plasma Membrane Neurotransmitter Transport Proteins, Guanidinoacetate N-Methyltransferase

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cerebral Creatine Deficiency Syndromes: Clinical Aspects, Treatment and Pathophysiology. https://app.cochat.ai/papers/10.1007/978-1-4020-6486-9_8
The paper
Stockler, S., Schutz, P. W., & Salomons, G. S. (2007). Cerebral Creatine Deficiency Syndromes: Clinical Aspects, Treatment and Pathophysiology. Subcellular Biochemistry. https://doi.org/10.1007/978-1-4020-6486-9_8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.